TOTAL-BODY CLEARANCE AND PLATINUM ACCUMULATION IN PATIENTS TREATED WITH CIS-DICHLORODIAMMINE PLATINUM (II)

被引：6

作者：

FISH, RG

SHELLEY, MD

GRIFFITHS, H

机构：

来源：

THERAPEUTIC DRUG MONITORING | 1984年 / 6卷 / 02期

关键词：

D O I：

10.1097/00007691-198406000-00021

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：251 / 252

页数：2

共 12 条

[1]

BANNISTER SJ, 1978, CLIN CHEM, V24, P877

[2] PLATINUM KINETICS IN PATIENTS TREATED WITH CIS-DICHLORODIAMMINE PLATINUM(II) [J].

BUICE, RG ;

SOLOWAY, MS .

THERAPEUTIC DRUG MONITORING, 1982, 4 (03) :293-296

[3]

CROM WR, 1981, CANCER CHEMOTH PHARM, V6, P95

[4]

DECONTI RC, 1973, CANCER RES, V33, P1310

[5]

EVANS WE, 1982, CANCER CHEMOTH PHARM, V10, P22

[6]

GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI

[7] PHARMACOKINETICS AND PROTEIN-BINDING OF CIS-DICHLORODIAMMINE PLATINUM (II) ADMINISTERED AS A ONE-HOUR OR AS A 20-HOUR INFUSION [J].

GULLO, JJ ;

LITTERST, CL ;

MAGUIRE, PJ ;

SIKIC, BI ;

HOTH, DF ;

WOOLLEY, PV .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :21-26

[8]

Prestayko AW, 1980, CISPLATIN CURRENT ST

[9]

SCHILSKY RL, 1982, CANCER TREAT REP, V66, P1767

[10]

STEWART DJ, 1982, CANCER CHEMOTH PHARM, V10, P51

← 1 2 →